Summary
Comments by the CEO
Group development

Group development

Development in the quarter and the period Financial position and cash flow Employees

Acquisitions
Business areas
Business areas
Development Labtech Development Medtech
Financial information by business area

Quarterly data

Net sales and EBITA
Financial information
Financial information
Group summary

Consolidated income statement

Consolidated statement of comprehensive income

Consolidated Balance sheet

Consolidated Statement of change in group equity

Consolidated cash flow statement

Key figures
Parent Company summary

Parent Company income statement

Parent Company balance sheet
Other information

Accounting policies

Risks and uncertainties

Transactions with related parties

Financial instruments

Pledged assets and contingent liabilities

Nomination Committee

Significant events after the end of the interim period

Affirmation

Auditor’s report

Definitions

Alternative performance measures
The share Video conference Financial calendar

Interim Report Q3 2026
/
Financial information
/
Other information
/
Pledged assets and contingent liabilities

Pledged assets and contingent liabilities

	Sep 30	Sep 30	Dec 31
SEKm	2026	2025	2025
Contingent liabilities	49	52	50

previous Financial instruments

next Nomination Committee

Download Report

BRUNKEBERGSTORG 5
111 51 STOCKHOLM
TEL: 08-420 03 830
info@add.life

Powered by OnlineReports

AddLife

Privacy Policy and Cookies

Loading...